Axsome Therapeutics Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

AXSM
Axsome Therapeutics

Last Price:

$103.78

Seasonality Move:

5.58%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here

Axsome Therapeutics Stock Forecast

Over the next 52 weeks, Axsome Therapeutics has on average historically risen by 97.5% based on the past 9 years of stock performance.
Axsome Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Is Axsome Therapeutics Stock Undervalued?

The current Axsome Therapeutics [AXSM] share price is $105.67. The Score for AXSM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Axsome Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Axsome Therapeutics has on average historically risen by 97.5% based on the past 9 years of stock performance.

Axsome Therapeutics Stock Rating

Sell

Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics overpriced?

Axsome Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Axsome Therapeutics Stock Price History

Is AXSM stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

axsome.com

52-Week Data

52-Week High:

139.13

52-Week Low:

64.11

Prediction Charts

Market Cap:

5.2B

Price in USD:

105.67

Volume:

979.5K

Beta:

1.63

Technical Analysis

SMA50:

112.93

SMA100:

108.33

SMA200:

99.54

52-Wk Change:

39.7%

Stock Predictions

Is Axsome Therapeutics stock public?

Yes, Axsome Therapeutics is a publicly traded company.
What is the Axsome Therapeutics stock quote today?

The Axsome Therapeutics stock price is 105.67 USD today.
How to buy Axsome Therapeutics stock online?

You can buy Axsome Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-24	104.48	105.41	105.81	103.15
Apr-25	104.31	106.27	106.80	104.31
Apr-28	106.91	107.24	109.71	106.69
Apr-29	107.62	109.92	111.42	107.22
Apr-30	109.94	112.29	113.00	109.59
May-1	111.21	112.24	113.30	109.88
May-2	113.10	112.21	114.01	111.13
May-5	114.08	116.49	120.00	113.61
May-6	115.76	112.16	117.37	110.61
May-7	111.15	110.86	112.94	110.02
May-8	110.18	108.86	112.25	108.03
May-9	108.86	107.76	110.16	107.66
May-12	106.23	110.16	110.95	106.01
May-13	110.11	105.67	110.28	105.22

Axsome Therapeutics Earnings

Axsome Therapeutics Earnings Report: Per Share Axsome Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Axsome Therapeutics Forecast Revenue Growth

Axsome Therapeutics Stock Analysis: Historical quarterly revenues per share for Axsome Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.91 per share, an increase this year of $1.40 per share, and an increase next year of $5.11 per share.

* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.